Clinical Trials Sponsored by ARC Devices

Total 5310 results

Abbott Medical Devices

Completed

Dependence of LV Hemodynamics on Pacing Site

Heart Failure

France
Abbott Medical Devices

Completed

Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients

Heart Failure | Ventricular Dyssynchrony

France
Abbott Medical Devices

No longer available

Emergency/Compassionate Use - AMPLATZER Duct Occluder

Patent | Ductus | Arteriosus
Abbott Medical Devices

Completed

ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System

Atherosclerosis | Peripheral Vascular Disease | Claudication

Austria, France, Germany, Belgium
Abbott Medical Devices

Completed

B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure Patients

Heart Diseases | Heart Failure | Ventricular Dysfunction

France
Abbott Medical Devices

Completed

RethinQ Study - Evaluating Pacing in Heart Failure Patients (RethinQ)

Heart Failure

United States
Abbott Medical Devices

Completed

Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configuration (PROMISE)

Sudden Cardiac Death

United States
Abbott Medical Devices

Completed

Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study

Heart Failure

United States
Abbott Medical Devices

Completed

Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia

Fibromyalgia

Belgium
Abbott Medical Devices

Completed

SUNBURST (Success Using Neuromodulation With BURST) Study (SUNBURST)

Chronic Pain

United States
Abbott Medical Devices

Completed

Study of New Implantable Loop Recorder

Syncope | Tachyarrhythmias

United States
Abbott Medical Devices

Completed

Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study (Star AF II)

Atrial Fibrillation

Canada, Australia
Abbott Medical Devices

Completed

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels (ABSORB UK)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United Kingdom
Abbott Medical Devices

Terminated

A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device (VELOCITY)

Mitral Regurgitation

United States
Abbott Medical Devices

Completed

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angina

Japan
Abbott Medical Devices

Withdrawn

ABSORB Post-Approval Clinical Study

Ischemic Heart Disease

United States
Abbott Medical Devices

Terminated

Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I) (ACT I)

Stroke | Atherosclerosis | Carotid Stenosis | Carotid Artery Disease

United States
Abbott Medical Devices

Unknown

Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back Pain

Discogenic Low Back Pain

Netherlands
Abbott Medical Devices

Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Thailand, Israel, Spain, Italy, United Kingdom, Malaysia, Austria, France, Germany, Poland
Abbott Medical Devices

Completed

A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population (SV JAPAN)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis

Japan
Abbott Medical Devices

Withdrawn

Frontier Registry II Bifurcation Stent System Registry

Coronary Artery Disease
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

France, Italy, Norway, China, Spain, Germany, United Kingdom, Switzerland, Israel, Denmark, Belgium, Austria, Poland, Australia, Portugal, Argentina, Brazil, Hungary, Latvia, Netherlands, India, Greece, Malaysia, Russian Federation, South... and more
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Abbott Medical Devices

Completed

Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT) (PROTECT)

Carotid Artery Disease

United States
Abbott Medical Devices

Completed

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery Restenosis

United States
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
Abbott Medical Devices

Completed

SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

Myocardial Ischemia | Coronary Artery Disease | Vascular Disease | Coronary Artery Stenosis | Everolimus

Netherlands, Germany, Denmark
Abbott Medical Devices

Completed

XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery (EXCEED)

Coronary Artery Disease | Atherosclerosis

United States
Abbott Medical Devices

Completed

DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)

Coronary Disease

Germany
Abbott Medical Devices

Completed

The TRIMAXX Coronary Stent Trial

Coronary Artery Disease

Brazil, Germany
Abbott Medical Devices

Completed

Vision II: Evaluation of GALILEO Intravascular Radiotherapy System

Coronary Artery Disease

France
Dune Medical Devices

Completed

Intraoperative Use of the BP Device for Detecting Positive Margins During Lumpectomy Procedure

Breast Cancer

Israel
IHU Strasbourg
ARC Foundation for Cancer Research

Withdrawn

Endoscopic Optical Imaging for Precision Oncology Treatment Applied to Colorectal Tumours (Elios-Color-on-Specimen)

Colorectal Cancer
IHU Strasbourg
ARC Foundation for Cancer Research

Terminated

Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment (iEXMachyna3)

Parathyroid Diseases | Thyroid Diseases | Liver Metastases | Liver Cancer | Digestive Cancer | Digestive Perfusion

France
Argon Medical Devices
NAMSA

Not yet recruiting

CLEANer Aspiration for Pulmonary Embolism (CLEAN-PE)

Cardiovascular Diseases | Venous Thromboembolism | Pulmonary Embolism | Acute Pulmonary Embolism

United States
Vitruvian Medical Devices, Inc.

Recruiting

Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers

Foot Ulcer, Diabetic

United States
Abbott Medical Devices
Abbott

Completed

LV Only MPP With SyncAV

Heart Failure | Left Bundle-Branch Block

United Kingdom, France, Italy, Canada
CID - Carbostent & Implantable Devices

Completed

The ILLUMINA Study. (ILLUMINA) (ILLUMINA)

Peripheral Arterial Disease

Italy, Germany, France
Abbott Medical Devices
Endosense

Completed

TactiCath® Prospective Effectiveness Pilot Study (EFFICAS II)

Paroxysmal Atrial Fibrillation

Czechia, Germany
Abbott Medical Devices
Endosense

Completed

TOCCATA - Touch+™ for Catheter Ablation (TOCCATA)

Atrial Fibrillation | Tachycardia, Supraventricular
CID - Carbostent & Implantable Devices

Completed

Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS (DEMONSTRATE)

Stable Angina | Unstable Angina | NSTEMI

Netherlands, Italy
Léman Micro Devices SA

Withdrawn

A Study to Demonstrate the Clinical Accuracy of the Smartphone Vital Signs System (SVSS)

Healthy Volunteers

Switzerland
Léman Micro Devices SA

Unknown

V-Sensors for Vitals: Assessment of the Accuracy of a Vital Sign Sensor Mounted on a Smartphone

Clinical Accuracy of Vital Sign Pressure Sensor
OhioHealth
Abbott Medical Devices

Withdrawn

Effect of Right Ventricular Lead Position on Defibrillation Threshold

Ventricular Fibrillation | Ventricular Tachycardia

United States
Minimally Invasive Devices, Inc.

Terminated

Post Market Study for FloShield 10mm Reusable Cannula and Blunt Obturator and Robotic FloShield

Cholecystectomy | Benign Hysterectomy | Salingo-oophorectomy

United States
Minimally Invasive Devices, Inc.

Completed

Comparison FloShield Air System Versus Clearify Visualization System (D-HELP)

Laparoscopic Surgery

United States
University of Birmingham
PSC Support; Life Arc

Not yet recruiting

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis (FARGO)

Inflammatory Bowel Diseases | Primary Sclerosing Cholangitis

United Kingdom
Centre Leon Berard
Janssen, LP; Fondation ARC

Recruiting

A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast Cancer (ABLE02)

Metastatic Breast Cancer

France

Clinical Trials Sponsored by ARC Devices

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations